Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/palatins-stock-plummets-43-as-lead-asset-fails-phiii-dry-eye-co-primary-endpoints/
https://www.prnewswire.com/news-releases/palatin-reports-second-quarter-fiscal-year-2024-financial-results-and-provides-corporate-update-302062737.html
https://www.prnewswire.com/news-releases/palatin-to-report-second-quarter-fiscal-year-2024-results-teleconference-and-webcast-to-be-held-on-february-15-2024-302058387.html
https://www.prnewswire.com/news-releases/palatin-announces-database-lock-for-pl9643-melody-1-pivotal-phase-3-clinical-trial-in-patients-with-dry-eye-disease-ded-302052721.html
https://www.indianpharmapost.com/news/palatin-completes-sale-of-vyleesi-to-cosette-pharmaceuticals-for-up-to-171-mn-15086
https://www.prnewswire.com/news-releases/palatin-completes-sale-of-vyleesi-to-cosette-pharmaceuticals-for-up-to-171-million-302020026.html
https://www.prnewswire.com/news-releases/palatin-receives-notice-of-acceptance-of-the-listing-standards-compliance-plan-from-nyse-american-302018227.html
https://www.prnewswire.com/news-releases/palatin-announces-preliminary-quarter-ended-september-30-2023-vyleesi-product-revenue-results-301961623.html
https://www.prnewswire.com/news-releases/palatin-announces-positive-preclinical-data-showing-synergistic-weight-loss-initiating-clinical-study-of-melanocortin-4-receptor-agonist--glp-1-in-obese-patients-301960009.html
https://www.prnewswire.com/news-releases/palatin-reports-fourth-quarter-and-fiscal-year-ended-2023-financial-results-and-provides-corporate-update-301941294.html